financetom
TMCI
financetom
/
Healthcare
/
TMCI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Treace Medical Concepts, Inc.TMCI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals in the United States.

The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity.

It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision; and Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot.

Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Latest News >
Research Alert: CFRA Keeps Hold Opinion On Shares Of Quanta Services, Inc.
Research Alert: CFRA Keeps Hold Opinion On Shares Of Quanta Services, Inc.
May 2, 2024
02:25 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our target to $265 from $235, valuing shares at 27.6x our 2025 EPS estimate, a premium to PWR's three-year average of 23.8x. We believe the premium is warranted...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Ventas, Inc.
Research Alert: CFRA Maintains Buy Opinion On Shares Of Ventas, Inc.
May 2, 2024
02:05 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lift our target by $2 to $52 on a forward P/FFO of 16.5x our 2024 FFO estimate, a premium to VTR's 15.5x 10-year average due to favorable demographic tailwinds...
Research Alert: CFRA Maintains Buy Opinion On Shares Of Sabre Corporation
Research Alert: CFRA Maintains Buy Opinion On Shares Of Sabre Corporation
May 2, 2024
02:15 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target by $0.30 to $3.50, using an EV/sales ratio of 1.9x our 2024 sales view, below peers and SABR's three-year average (~2.4x) on its high debt load...
Research Alert: CFRA Maintains Hold Opinion On Shares Of Advanced Energy Industries, Inc.
Research Alert: CFRA Maintains Hold Opinion On Shares Of Advanced Energy Industries, Inc.
May 2, 2024
02:25 PM EDT, 05/02/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We cut our 12-month target by $8 to $100 on a P/E of 18x our 2025 EPS view, in line with EMS peers. We cut our 2024 EPS view to...
Copyright 2023-2025 - www.financetom.com All Rights Reserved